Our observation of reduced serum DNase activity confirms a previous study [46] and builds on studies showing reduced plasma concentrations of Gelsolin in COVID-19; Gelsolin depolymerizes filamentous actin, an inhibitor of DNAse activity [47,48,49]. This evidence concerns the gene GSN and COVID-19.